GRX - Tekla Life Sciences Investors: 8% Yield 7% Discount January, 09 2021 09:15 AM The Gabelli Healthcare & Wellness Trust of Beneficial Interest HQL has outperformed other healthcare-oriented CEFs over the past year. It's selling at a -7.27% discount to NAV. It yields 7.94%, and is a good watchlist candidate. For further details see: Tekla Life Sciences Investors: 8% Yield, 7% Discount